These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39192648)

  • 1. The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability.
    Zhang D; Mai L; Zhang L; Huang G; Lin Z; Wang S; Rao G; Xie S; Pan C
    Recent Pat Anticancer Drug Discov; 2024 Aug; ():. PubMed ID: 39192648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
    He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
    Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
    Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
    Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
    Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
    Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N
    Xu K; Dai X; Wu J; Wen K
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.
    Peng WX; Liu F; Jiang JH; Yuan H; Zhang Z; Yang L; Mo YY
    Genes Dis; 2023 Mar; 10(2):554-567. PubMed ID: 37223505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
    Liang J; Cai H; Hou C; Song F; Jiang Y; Wang Z; Qiu D; Zhu Y; Wang F; Yu D; Hou J
    Clin Sci (Lond); 2023 Sep; 137(17):1373-1389. PubMed ID: 37615536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
    Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
    Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism.
    Pu J; Wang J; Qin Z; Wang A; Zhang Y; Wu X; Wu Y; Li W; Xu Z; Lu Y; Tang Q; Wei H
    Front Oncol; 2020; 10():578816. PubMed ID: 33224879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel m6A reader RBFOX2 expression is increased in oral squamous cell carcinoma and promotes tumorigenesis.
    Arumugam P; M SM; Jayaseelan VP
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 126(1):102041. PubMed ID: 39244024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.
    Yang YT; Wang YF; Lai JY; Shen SY; Wang F; Kong J; Zhang W; Yang HY
    Cancer Sci; 2016 Nov; 107(11):1581-1589. PubMed ID: 27560546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2BP2 Regulates MALAT1 by Serving as an N6-Methyladenosine Reader to Promote NSCLC Proliferation.
    Han L; Lei G; Chen Z; Zhang Y; Huang C; Chen W
    Front Mol Biosci; 2021; 8():780089. PubMed ID: 35111811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.
    Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F
    Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
    He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
    Mol Cell Biochem; 2024 Jul; 479(7):1707-1720. PubMed ID: 38822192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A reader IGF2BP2 promotes lymphatic metastasis by stabilizing DPP4 in papillary thyroid carcinoma.
    Wang W; Ding Y; Zhao Y; Li X
    Cancer Gene Ther; 2024 Feb; 31(2):285-299. PubMed ID: 38102465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.